Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Donepezil

A reversible acetylcholinesterase inhibitor that raises levels of acetylcholine, a chemical messenger linked to memory, in the brain. Born in Japan from research begun in 1983 and approved in the United States in 1996, it is used for the symptoms of Alzheimer's dementia. This family brings together the active ingredient, pharmacopoeial impurities, metabolites, labelled standards, nitrosamines and other impurities.

Did you know?Chemist Hachiro Sugimoto, who led the research team, began working on such medicines because his mother suffered from dementia.

DonepezilGo to the active ingredient →
DonepezilActive ingredientDonepezilCat. No. P-D169-001CAS 120014-06-4
Donepezil-d5Isotopically labelledDonepezil-d5Cat. No. P-D169-021CAS 1128086-25-8

EDQM standards 1

The official European Pharmacopoeia standards for this family.

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.